Business · 09/12/1998Updated: 10/17/2026 · 1 min read
FDA Announces 1999 Meetings of Clinical Hold Review Committee for Investigational Biological Products
Summary
The FDA is inviting biological product companies to submit confidential reviews of clinical holds on investigational biological product trials from the past 12 months for review by the clinical hold review committee.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →